In this episode, Rick Zimmerman, MD, MPH, FAAFP, discusses RSV vaccines in older adults, including: Breakthroughs in RSV vaccine developmentRSV vaccine snapshot in older adultsFDA-approved RSV vaccines for older adultsCDC evidence to recommendations framework for vaccinesRSV burden in older populationsBenefits and harms of RSV vaccinationRSV vaccine efficacy and safety in older adultsCDC Advisory Committee Immunization Practices recommendations for RSV vaccines in older adultsPopulations at high risk for severe RSV diseaseVaccination considerations based on the upcoming RSV seasonFaculty:Richard Zimmerman, MD, MPH, FAAFPProfessorDepartment of Family Medicine and Clinical Epidemiology  University of PittsburghPittsburgh, PennsylvaniaContent based on an online CME program supported by an independent educational grant from GlaxoSmithKline.Link to full program: https://bit.ly/49YBZ4rLink to downloadable slides: https://bit.ly/3GocjRe